Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Avantor, Inc. (AVTR) for potential corporate wrongdoing. The firm is encouraging investors who purchased Avantor securities before March 5, 2024, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis in securities fraud class actions.
Does Hedge Fund Accumulation Ahead of Earnings Call Reframe Avantor’s (AVTR) Institutional Confidence Story?
Ahead of its Q2 2026 earnings release on July 29, Avantor (AVTR) has seen a significant increase in holdings by institutional investors, including several hedge funds like Greenhaven Associates. This renewed institutional interest is seen as a key indicator of confidence in the company's future despite ongoing concerns about margin pressure and flat revenue guidance. The upcoming earnings call will be crucial for assessing whether this confidence aligns with Avantor's actual financial progress.
AVTR Shareholders Have Opportunity to Lead Avantor, Inc. Class Ac
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Avantor, Inc. (NYSE:AVTR) and its officers, alleging violations of federal securities laws. The lawsuit claims that Avantor issued materially false and misleading statements about its competitive positioning and adverse effects from increased competition between March 5, 2024, and October 28, 2025. Investors who suffered losses have until December 29, 2025, to request to be appointed lead plaintiff.
Avantor Inc stock highlights life sciences exposure as investors weigh long term demand
Avantor Inc. (AVTR) serves as a critical supplier to the life sciences and advanced technology industries, including biopharma manufacturers and semiconductor markets. The company's business model focuses on recurring revenue from consumables, equipment, and services used in research labs and production processes. Avantor's diversified end markets and essential role in global health care and technology trends position it for long-term growth, despite broader market sentiment changes.
Levi & Korsinsky Notifies Avantor, Inc. (AVTR) Investors - Lead Plaintiff Deadline on December 29, 2025
Levi & Korsinsky, LLP has announced a securities class action lawsuit filed on behalf of investors who purchased Avantor, Inc. (NYSE:AVTR) securities. The lawsuit alleges that Avantor made false statements and concealed that its competitive positioning was weaker and that it was experiencing negative effects from increased competition between March 5, 2024, and October 28, 2025. Investors who suffered losses on their Avantor investment have until December 29, 2025, to act as lead plaintiff.
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Avantor, Inc. (AVTR) for corporate wrongdoing. The firm encourages shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them for more information and to assist in the investigation. The representation of investors in class actions is on a contingency fee basis.
Securities Class Action Lawsuit Filed Against Avantor, Inc. (AVTR) - Levi & Korsinsky Represents Shareholders
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Avantor, Inc. (NYSE:AVTR) on behalf of investors who suffered losses between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor and its defendants made false statements regarding the company's competitive positioning and experience with increased competition. Shareholders are encouraged to learn about their rights to seek recovery.
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
Avantor, Inc. (NYSE: AVTR) announced it will release its second quarter 2026 financial results before market open on Wednesday, July 29, 2026. The company will also host a conference call to discuss these results on the same day at 8:00 a.m. Eastern Daylight Time. Investors can access a live audio webcast of the session and a 30-day replay on Avantor's investor relations website.
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE:AVTR) securities. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing, particularly for investors who held shares prior to March 5, 2024. The firm encourages affected stockholders to contact them to learn more and assist with the investigation, with no upfront cost to investors.
Join Class Action to Recover Losses from Avantor, Inc. (AVTR) – Contact Levi & Korsinsky Before December 29, 2025
Levi & Korsinsky, LLP has filed a class action securities lawsuit against Avantor, Inc. (NYSE: AVTR) on behalf of shareholders who suffered losses between March 5, 2024, and October 28, 2025. The lawsuit alleges that Avantor misrepresented its competitive position and concealed negative effects from increased competition. Shareholders are encouraged to contact Levi & Korsinsky to learn more about their rights to recover losses.
Smart Money Is Buying Avantor Inc (AVTR)
Institutional investors significantly increased their stakes or initiated new positions in Avantor Inc (AVTR), a leading supplier to the life sciences industry, during the last quarter. Notable buyers include Ed Wachenheim, Joel Greenblatt, Cliff Asness, Rob Olstein, Donald Yacktman, Ray Dalio, Jeremy Grantham, and Lee Ainslie, with several highlighting confidence in Avantor's long-term value and recovery potential. This broad accumulation from value-oriented, quantitative, and fundamental investors suggests growing belief that AVTR is undervalued despite recent underperformance.
Investors in Avantor, Inc. (AVTR): Protect Your Rights - Contact Levi & Korsinsky Before December 29, 2025
A securities class action lawsuit has been filed against Avantor, Inc. (NYSE:AVTR) on behalf of investors who suffered losses due to alleged securities fraud between March 5, 2024, and October 28, 2025. The lawsuit claims that Avantor made false statements regarding its competitive positioning and negative effects from increased competition. Levi & Korsinsky, LLP is encouraging affected shareholders to contact them to explore potential recovery options before December 29, 2025.
Class Action Filed Against Avantor, Inc. (AVTR) Over Securities Violations - Contact Levi & Korsinsky Today
A class action lawsuit has been filed against Avantor, Inc. (AVTR) on behalf of investors who purchased its securities between March 5, 2024, and October 28, 2025. The lawsuit, brought by Levi & Korsinsky, LLP, alleges that Avantor made false statements regarding its competitive positioning and suffered negative effects from increased competition, rendering the company's representations materially misleading. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky to explore their recovery options.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Avantor, Inc. (NYSE:AVTR) regarding potential corporate wrongdoing by the company's officers and/or directors. The firm is encouraging Avantor stockholders who purchased securities before March 5, 2024, and still hold them, to come forward and assist in the investigation. They emphasize that there is no cost to investors as the firm operates on a contingency fee basis.
Bernstein resumes Avantor stock coverage with Market Perform rating
Bernstein SocGen Group has resumed coverage of Avantor Inc. (NYSE:AVTR) with a Market Perform rating and a $10.50 price target, noting the company faces challenges like market share losses to Thermo and pricing pressure. While Avantor reported a loss of $0.81 per share over the last twelve months, analysts forecast a return to profitability in fiscal 2026. The company also faces risks from AI disruption in its preclinical and consumable products segments.
AVTR Forecast — Price Target — Prediction for 2027
Avantor, Inc. (AVTR) currently trades at $10.28, having increased by 1.98% in the last 24 hours. Analysts provide a wide forecast range for AVTR's price, with a maximum estimate of $19.00 and a minimum of $7.00. The company is set to release its next earnings report on July 23, 2026, and does not pay dividends.
Avantor, Inc. Actuals & Estimates (NYSE:AVTR)
This article provides an in-depth financial overview of Avantor, Inc. (NYSE:AVTR), including its stock performance, analyst estimates, earnings reports, and other key financial metrics. It covers the current stock price, market capitalization, volatility, and future revenue and earnings expectations, noting that the company does not pay dividends.
Price to earnings forward of Avantor, Inc. – NYSE:AVTR
This article displays the "Price to earnings forward" metric for Avantor, Inc. (NYSE: AVTR). It indicates the value and change of this financial metric, noting that the data is presented on a financial overview page. The content is primarily a data placeholder within a financial information platform.
Price to sales forward of Avantor, Inc. – NYSE:AVTR
This article displays the "Price to sales forward" metric for Avantor, Inc. (NYSE: AVTR) and indicates that there are no current trades for the company as the market is closed. It also lists the various financial and community features available on the TradingView platform for this stock.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims on behalf of investors who purchased Avantor, Inc. (AVTR) securities prior to March 5, 2024, and continue to hold them. The investigation focuses on possible corporate wrongdoing by Avantor officers and/or directors. The firm encourages affected investors to contact them for more information, noting that they operate on a contingency fee basis.
Avantor Inc (AVTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Avantor Inc (AVTR), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The analysis suggests a "Sell" signal based on aggregated indicators, with specific breakdowns for MACD, RSI, and moving averages. It also includes FAQs explaining technical ratings and moving averages.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Avantor, Inc. (AVTR) regarding potential corporate wrongdoing, focusing on investors who purchased securities before March 5, 2024. The firm encourages these investors to reach out to assist with the investigation, which is conducted on a contingency fee basis. As a nationally recognized firm, Bronstein, Gewirtz & Grossman, LLC aims to restore investor capital and ensure corporate accountability.
Form 4 Avantor Inc For: 22 June By Investing.com
This article provides details of a Form 4 filing for Avantor Inc. on June 22. It mentions the company's stock symbol AVTR, which experienced a -2.40% change. The content primarily focuses on presenting various financial market data and unrelated news, with the Form 4 filing itself being the central but brief subject.
Avantor (AVTR) executive has shares withheld to cover RSU taxes
Avantor, Inc. executive Corey Walker, President of VWR Distribution & Services, had 3,010 shares of Common Stock withheld at $9.58 per share to cover tax obligations related to vesting Restricted Stock Units (RSUs). This transaction was a tax-related disposition, not an open-market sale, and resulted in Walker directly holding 384,535 Avantor common shares afterward. The Form 4 filing details this transaction, indicating it was specifically for tax withholding purposes.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Avantor, Inc. (NYSE:AVTR) and its officers/directors. The firm is encouraging investors who purchased Avantor securities before March 5, 2024, and still hold them, to participate in the investigation by visiting their website or contacting them directly. The investigation aims to restore investor capital and ensure corporate accountability.
What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders
Wolfe Research initiated coverage on Avantor (AVTR) with an "Underperform" rating, citing flat sales, margin pressure, competitive losses in its VWR distribution business, and concerns about its product strategy and reliance on acquisitions. Avantor's Q1 2026 results showed flat sales and decreased net income, aligning with Wolfe's concerns. The report suggests investors should closely examine the potential for sustained margin compression and the company's ability to stabilize its core business and earnings power.
What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders
Wolfe Research initiated coverage on Avantor (AVTR) with an "Underperform" rating, citing flat sales, margin pressure, and competitive losses in its VWR distribution business. The report challenges Avantor's growth and margin prospects, especially given its recent Q1 2026 results that showed stagnant revenue and declining net income. Investors are prompted to reassess Avantor’s ability to improve its earnings amid these concerns, despite some analyst forecasts predicting future revenue and earnings growth.
Avantor Inc (AVTR) Institutional Confidence
Avantor Inc (AVTR) currently holds an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Its institutional shareholding proportion is 104.03%, marking an 11.03% decrease quarter-over-quarter. Barrow Hanley is the largest institutional shareholder, with 20.87 million shares, representing 3.31% of the shares outstanding.
Avantor Inc (AVTR) Earnings Forecast: Future EPS & Revenue Growth Estimates
Avantor Inc (AVTR) has an earnings forecast score of 6.11, placing it 170th in the Healthcare Equipment & Supplies industry. Analysts have a consensus target price of $13.00 for AVTR, with a majority rating it as "Hold." The company's expected revenue for the next quarter is $1.61 billion, and its EPS for the upcoming quarter is projected at $0.19.
Avantor Inc (AVTR) Valuation: PE, PB & Fair Value Analysis
Avantor Inc (AVTR) has a current valuation score of 8.57, placing it 90th out of 204 companies in the Healthcare Equipment & Supplies industry. The company's P/E ratio is -11.68, which is significantly below its recent high and above its recent low. Key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
Avantor Inc (AVTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for Avantor Inc (AVTR), categorizing its revenue by business segments (Proprietary materials & consumables, Third party materials & consumables) and by geographical regions (United States, All other countries). The data, updated as of April 6, indicates that proprietary materials and consumables make up a larger portion of revenue, and revenue is almost evenly split between the United States and international markets. The article also includes current stock performance data.
(AVTR) and the Role of Price-Sensitive Allocations
This article, published by Stock Traders Daily, provides an AI-driven analysis of Avantor Inc. (NASDAQ: AVTR). It highlights strong near and mid-term sentiment but a weak long-term outlook, noting that resistance is being tested. The analysis offers specific institutional trading strategies, including long and short setups with defined entry, target, and stop-loss zones.
Sector Gamma AS Has $7.97 Million Holdings in Avantor, Inc. $AVTR
Sector Gamma AS significantly increased its stake in Avantor, Inc. (NYSE:AVTR) by 45.8% in the fourth quarter, bringing their total holdings to $7.97 million. This move is part of a broader trend of institutional investment, with 95.08% of Avantor's stock now held by institutions and hedge funds. Despite recent positive earnings results, analysts maintain a cautious "Reduce" rating for Avantor with an average price target of $10.57.
Private Management Group Inc. Purchases 823,572 Shares of Avantor, Inc. $AVTR
Private Management Group Inc. increased its stake in Avantor, Inc. (NYSE:AVTR) by 50.4% in the fourth quarter, acquiring an additional 823,572 shares. Other institutional investors also adjusted their positions in Avantor, while company insiders made purchases. Analysts currently have an average "Reduce" rating on the stock with a consensus target price of $10.57.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Avantor, Inc. (AVTR) regarding potential corporate wrongdoing. The firm is encouraging shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them to assist in the investigation. The investigation aims to determine if Avantor and its officers/directors engaged in misconduct, with the law firm operating on a contingency fee basis.
Avantor | 8-K: Current report
This article from moomoo Investments announces Avantor's 8-K current report, published by the SEC on April 1. It states that the announcement is a separate document and includes disclaimers about the informational and educational nature of its content, emphasizing that it does not constitute investment advice.
TD Asset Management Inc Cuts Holdings in Avantor, Inc. $AVTR
TD Asset Management Inc. reduced its stake in Avantor, Inc. by 6.9% in the fourth quarter, selling 170,996 shares. Despite this, institutional investors still hold a significant 95.08% of the company's stock. Avantor faces cautious analyst sentiment, evidenced by an average "Reduce" rating and a target price of $10.57, yet insiders have recently purchased shares, and the company's latest quarterly results slightly exceeded expectations for both EPS and revenue.
Avantor Jumps 6.9% Amid Sector-Wide Rally
Avantor Inc. (NYSE:AVTR) saw its shares jump 6.9% to $9.79 amidst a broader sector-wide rally in medical instruments and supplies companies. This synchronized gain, with peers also advancing, suggests a rotation of capital into the sector rather than company-specific news. The rally pushed Avantor's market capitalization to $6.7 billion, with traders watching if this momentum will lead to a sustained trend or prove to be a short-term sentiment spike.
Avantor (AVTR) Stock Grinds Higher As Turnaround Story Builds
Avantor (AVTR) stock is trending up, showing a 7.37% increase due to strong sentiment regarding its strategic growth initiatives and a perceived management-led turnaround. RBC Capital Markets resumed coverage with a Sector Perform rating and a $9 price target, noting that while the company has ambitious free cash flow targets for 2026, traders are focused on execution rather than mere hype. The stock's recent performance indicates a classic turnaround pattern, with significant short-term gains, while the appointment of Gerard Porreca as EVP, Quality and Regulatory, supports the long-term rebuild.
Avantor, Inc. (AVTR)
This article provides a brief mention of Avantor, Inc. (AVTR) but contains no substantive content regarding the company. It primarily consists of navigational elements, a date and author, and then immediately transitions into "Related News" and other company updates from various sectors. The core article about Avantor appears to be missing or returned blank.
Avantor Sees Unusually Large Options Volume (NYSE:AVTR)
Avantor (NYSE:AVTR) experienced unusually high options trading volume, with call options increasing by 244% on Monday. The stock rose 6.4% to $9.75, despite analysts rating it "Reduce" with an average price target of $10.57. Recent Q1 earnings beat estimates, insiders purchased shares, and institutional ownership remains strong at 95.08%.
Has Avantor's Q4 Report Fully Priced In the Bad News
Avantor's Q4 2025 earnings report resulted in a stock sell-off despite a revenue beat, due to significant margin contraction and a cautious FY2026 outlook. The company has launched a "Revival program" to address these issues, framing 2026 as a "transition and investment year" with expected margin pressure. While the stock is trading near its 52-week low, signaling that much of the negative sentiment is priced in, its recovery hinges on the successful execution of this high-stakes turnaround plan.
Avantor, Inc. Trade Ideas — XETR:AVG
This article compiles several trade ideas and analyses for Avantor, Inc. (XETR:AVG, NYSE:AVTR) from various traders on TradingView. The prevailing sentiment is bullish, with one detailed analysis suggesting a long position given strong fundamentals, capital inflows, and technical indicators, targeting prices up to $34.54. Other contributors discuss price trends, Bollinger Bands, volume analysis, and potential breakouts based on technical patterns and upcoming earnings.
Avantor, Inc. Cash Flow – XETR:AVG
This article provides details on Avantor, Inc.'s cash flow performance, highlighting its free cash flow for Q1 2026 at 21.81 million EUR and for 2025 at 421.45 million EUR. It also notes the operating cash flow for 2025 was 531.12 million EUR. The report includes a tabular breakdown of cash flow activities from 2015 to 2025.
Price to sales ratio of Avantor, Inc. – XETR:AVG
The article focuses on the price-to-sales ratio of Avantor, Inc. (XETR:AVG) as listed on TradingView. It provides a brief financial overview of the company, indicating that the market is currently closed with no trades. The content highlights the availability of financial data and market information on the TradingView platform for this specific stock.
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avantor, Inc. (NYSE: AVTR) securities. The firm encourages investors who bought Avantor shares before March 5, 2024, and still hold them, to contact them to assist with the investigation. The investigation focuses on whether Avantor and its officers engaged in corporate wrongdoing.
Reinhart Partners LLC. Sells 202,842 Shares of Avantor, Inc. $AVTR
Reinhart Partners LLC significantly reduced its stake in Avantor, Inc. (NYSE:AVTR) by 29.5% in the fourth quarter, selling 202,842 shares and retaining 484,963 shares valued at approximately $5.56 million. Despite Avantor beating its recent quarterly EPS and revenue estimates, analysts maintain a cautious outlook with a consensus "Reduce" rating and an average price target of $10.57. The stock recently traded at $8.95 and has seen mixed analyst ratings including "neutral," "sector perform," and "underperform."
Responsive Playbooks and the AVTR Inflection
The article discusses the stock analysis for Avantor Inc. (NASDAQ: AVTR), highlighting a potential shift from strong near and mid-term sentiment to a weak long-term outlook. It identifies a mid-channel oscillation pattern and presents various AI-generated trading strategies (Position Trading, Momentum Breakout, Risk Hedging) with specific entry, target, and stop-loss levels. The analysis emphasizes a significant risk-reward short setup for AVTR.
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Avantor, Inc. (AVTR) concerning potential corporate wrongdoing by its officers and/or directors. The firm is encouraging shareholders who purchased Avantor securities before March 5, 2024, and still hold them, to contact them for more information and to assist in the investigation. The representation of investors in such class actions is on a contingency fee basis.
Wolfe Research initiates Avantor stock with underperform rating By Investing.com
Wolfe Research has initiated coverage on Avantor Inc. (NYSE:AVTR) with an Underperform rating and a $7.00 price target, citing concerns over multiple years of growth and margin challenges. Despite the negative outlook from Wolfe Research, InvestingPro analysis suggests the stock may be undervalued at its current trading price of $9.19, and the company is expected to return to profitability this year. Recent company news includes Avantor surpassing analyst expectations for Q1 2026 earnings and revenue, RBC Capital initiating coverage with a Sector Perform rating, and a new Executive Vice President joining the team.
